Search results
Amarin's (AMRN) Q1 Earnings Top, Vascepa Sales Fall
Zacks via Yahoo Finance· 1 year agoAmarin Corporation Plc AMRN reported first-quarter 2023 adjusted earnings of 2 cents per share, which beat the Zacks Consensus Estimate and our model...
Amarin's New Vascepa Data Shows Significant Reduction In Heart Attack Subtypes
Benzinga via Yahoo Finance· 2 years agoNew data shows that Amarin Corporation plc's (NASDAQ: AMRN) Vascepa/Vazkepa (icosapent ethyl)...
Amarin (AMRN) Q3 Earnings Beat, Sales Hurt by Vascepa Generics
Zacks via Yahoo Finance· 2 years agoAmarin's (AMRN) Vascepa sales decline year over year amid rising generic competition and the...
Amarin's (AMRN) Q4 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 1 year agoAmarin Corporation Plc AMRN reported adjusted earnings of 2 cents per share in fourth-quarter 2022,...
Amarin's (AMRN) Q4 Preliminary Revenues Top Expectations
Zacks via Yahoo Finance· 1 year agoAmarin Corporation (AMRN) expects to generate total revenues in the range of $88-$90 million in...
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 month agoImage source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q1 2024 Earnings Call May 01, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and...
Amarin Corp PLC (AMRN) Faces Revenue Decline Amidst Generic Competition
GuruFocus.com via Yahoo Finance· 3 months agoTotal Revenue: Q4 revenue decreased by 17% year-over-year to $75 million. Net Loss: Reported a net...
Why Amarin Stock Skyrocketed Today
Motley Fool via Yahoo Finance· 5 months agoShares of Amarin (NASDAQ: AMRN) skyrocketed 32.9% on Wednesday after the biopharmaceutical company announced strong preliminary fiscal fourth-quarter...
Why Amarin Stock Tumbled This Week
Motley Fool· 1 year agoWhat happened Amarin (NASDAQ: AMRN) stock shed 11.9% of its value this week, according to data provided by S&P Global Market Intelligence. The...
Why Amarin Stock Was Rocketing Higher on Wednesday
Motley Fool via Yahoo Finance· 2 months agoAny one-product company that receives good news about that product will likely attract investors. That was the case Wednesday with Amarin (NASDAQ: AMRN),...
